21 – 30 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Clinical parameters predicting complications in native kidney biopsies
(
- Contribution to journal › Article
-
Mark
COVID-19 and ANCA-associated vasculitis : Recommendations for vaccine preparedness and the use of rituximab
(
- Contribution to journal › Letter
-
Mark
CKD Progression and Mortality Among Men and Women : A Nationwide Study in Sweden
(
- Contribution to journal › Article
-
Mark
Analyses of registry data of patients with anti-GBM and antineutrophil cytoplasmatic antibody-associated (ANCA) vasculitis treated with or without therapeutic apheresis
(
- Contribution to journal › Article
-
Mark
Treatment practices and outcomes in incident peritoneal dialysis patients : The Swedish Renal Registry 2006-2015
(
- Contribution to journal › Article
- 2020
-
Mark
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
(
- Contribution to journal › Scientific review
-
Mark
Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in ESKD patients
(
- Contribution to journal › Article
-
Mark
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
(
- Contribution to journal › Article
-
Mark
2020 international consensus on ANCA testing beyond systemic vasculitis
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Anti-glomerular basement membrane disease : an update on subgroups, pathogenesis and therapies
(
- Contribution to journal › Scientific review